Key result
Mitral valve replacement with the St Jude Medical Epic porcine bioprosthesis demonstrated satisfactory midterm outcomes, with an 80.9% freedom from all-cause death and 93.1% freedom from structural valve deterioration at 5 years.
Population
117 patients who underwent mitral valve replacement at a single center in Japan. Indications included mitral…
Design
Cohort
Follow-up
mean 2.6±1.7 years
Authors
Loading...
Supports Epic mitral bioprosthesis use in selected patients; leaves open need for randomized and longer-term data.
Cohort (n=117)
No
The St Jude Medical Epic porcine bioprosthesis in the mitral position demonstrated satisfactory mid-term clinical outcomes and durability, with 93.1% freedom from structural valve deterioration at 5 years.
Nakazato et al. (2018) conducted a cohort in Mitral valve disease requiring replacement (n=117). St Jude Medical Epic porcine bioprosthesis was evaluated on Freedom from all-cause death at 5 years. Mitral valve replacement with the St Jude Medical Epic porcine bioprosthesis demonstrated satisfactory midterm outcomes, with an 80.9% freedom from all-cause death and 93.1% freedom from structural valve deterioration at 5 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: